Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- PMID: 32020029
- PMCID: PMC7054408
- DOI: 10.1038/s41422-020-0282-0
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment in
-
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4. Int J Antimicrob Agents. 2020. PMID: 32145363 Free PMC article. No abstract available.
-
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.Ann Rheum Dis. 2020 May;79(5):666-667. doi: 10.1136/annrheumdis-2020-217367. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241791 No abstract available.
-
Chloroquine hype is derailing the search for coronavirus treatments.Nature. 2020 Apr;580(7805):573. doi: 10.1038/d41586-020-01165-3. Nature. 2020. PMID: 32332911 No abstract available.
-
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):256-257. doi: 10.1093/ehjcvp/pvaa041. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 32347923 Free PMC article. No abstract available.
Similar articles
-
Rapid review for the anti-coronavirus effect of remdesivir.Drug Discov Ther. 2020;14(2):73-76. doi: 10.5582/ddt.2020.01015. Drug Discov Ther. 2020. PMID: 32378648 Review.
-
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0. Nat Rev Drug Discov. 2020. PMID: 32127666 No abstract available.
-
Remdesivir against COVID-19 and Other Viral Diseases.Clin Microbiol Rev. 2020 Oct 14;34(1):e00162-20. doi: 10.1128/CMR.00162-20. Print 2020 Dec 16. Clin Microbiol Rev. 2020. PMID: 33055231 Free PMC article. Review.
-
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.Antimicrob Agents Chemother. 2020 Apr 21;64(5):e00399-20. doi: 10.1128/AAC.00399-20. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32152082 Free PMC article. Review.
-
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861965 Free PMC article. Review.
Cited by
-
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.PLoS Med. 2024 Sep 12;21(9):e1004428. doi: 10.1371/journal.pmed.1004428. eCollection 2024 Sep. PLoS Med. 2024. PMID: 39264960 Free PMC article. Clinical Trial.
-
Among Patients with COVID-19, should Remdesivir be Used for Treatment? A Systematic Review and Meta-analysis.Acta Med Philipp. 2024 Aug 15;58(14):50-66. doi: 10.47895/amp.vi0.7288. eCollection 2024. Acta Med Philipp. 2024. PMID: 39238554 Free PMC article.
-
Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus.J Enzyme Inhib Med Chem. 2024 Dec;39(1):2390909. doi: 10.1080/14756366.2024.2390909. Epub 2024 Aug 29. J Enzyme Inhib Med Chem. 2024. PMID: 39206852 Free PMC article.
-
An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19.Clin Pract. 2024 Aug 20;14(4):1601-1614. doi: 10.3390/clinpract14040129. Clin Pract. 2024. PMID: 39194933 Free PMC article.
-
An in vitro study for reducing the cytotoxicity and dose dumping risk of remdesivir via entrapment in nanostructured lipid carriers.Sci Rep. 2024 Aug 21;14(1):19360. doi: 10.1038/s41598-024-70003-7. Sci Rep. 2024. PMID: 39169059 Free PMC article.
References
-
- Huang Chaolin, Wang Yeming, Li Xingwang, Ren Lili, Zhao Jianping, Hu Yi, Zhang Li, Fan Guohui, Xu Jiuyang, Gu Xiaoying, Cheng Zhenshun, Yu Ting, Xia Jiaan, Wei Yuan, Wu Wenjuan, Xie Xuelei, Yin Wen, Li Hui, Liu Min, Xiao Yan, Gao Hong, Guo Li, Xie Jungang, Wang Guangfa, Jiang Rongmeng, Gao Zhancheng, Jin Qi, Wang Jianwei, Cao Bin. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
-
- Zhou, P. et al. Nature (accepted).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials